Heron Therapeutics (HRTX) PT Lowered to $32 at JMP Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Nasdaq hits record high after softer jobs data cuts rate-hike bets
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
Heron Therapeutics (HRTX) Pricing 8.57M Share Offering at $17.50/Sh
October 4, 2019 5:46 AM EDTHeron Therapeutics, Inc. (NASDAQ: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced the pricing of an underwritten public offering of 8,571,429 shares of its common stock at a price of... More
Heron Therapeutics (HRTX) Announces Proposed Common Offering
October 3, 2019 4:02 PM EDTHeron Therapeutics, Inc. (NASDAQ: HRTX) today announced that it intends to offer and sell shares of its common stock in an underwritten registered public offering. Heron intends to grant the underwriters of the offering a 30-day option to purchase up to an additional 15%... More
